Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Haematologica. 2011 Apr;96(4):558-66. doi: 10.3324/haematol.2010.033167.
Mediastinal gray zone lymphoma is a newly recognized entity with transitional morphological and immunophenotypic features between the nodular sclerosis subtype of Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Diagnostic criteria for mediastinal gray zone lymphoma are still challenging, and the optimal therapy is as yet undetermined. Epigenetic changes have been implicated in the loss of the B-cell program in classical Hodgkin's lymphoma, and might provide a basis for the immunophenotypic alterations seen in mediastinal gray zone lymphoma.
We performed a large-scale DNA methylation analysis of microdissected tumor cells to investigate the biological underpinnings of mediastinal gray zone lymphoma and its association with the related entities classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma, making comparisons with the presumptively less related diffuse large B-cell lymphoma.
Principal component analysis demonstrated that mediastinal gray zone lymphoma has a distinct epigenetic profile intermediate between classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma but remarkably different from that of diffuse large B-cell lymphoma. Analysis of common hypo- and hypermethylated CpG targets in mediastinal gray zone lymphoma, classical Hodgkin's lymphoma, primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma was performed and confirmed the findings of the principal component analysis. Based on the epigenetic profiles we were able to establish class prediction models utilizing genes such as HOXA5, MMP9, EPHA7 and DAPK1 which could distinguish between mediastinal gray zone lymphoma, classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma with a final combined prediction of 100%.
Our data confirm a close relationship between mediastinal gray zone lymphoma and both classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. However, important differences were observed as well, allowing a clear distinction from both parent entities. Thus, mediastinal gray zone lymphoma cannot be assigned to either classical Hodgkin's lymphoma or primary mediastinal large B-cell lymphoma, validating the decision to create an intermediate category in the World Health Organization classification.
纵隔灰色区淋巴瘤是一种新认定的实体,具有结节性硬化型霍奇金淋巴瘤和原发性纵隔大 B 细胞淋巴瘤之间过渡的形态学和免疫表型特征。纵隔灰色区淋巴瘤的诊断标准仍然具有挑战性,最佳治疗方法尚未确定。表观遗传改变与经典霍奇金淋巴瘤中 B 细胞程序的丧失有关,并且可能为纵隔灰色区淋巴瘤中所见的免疫表型改变提供基础。
我们对微切割肿瘤细胞进行了大规模的 DNA 甲基化分析,以研究纵隔灰色区淋巴瘤的生物学基础及其与相关实体经典霍奇金淋巴瘤和原发性纵隔大 B 细胞淋巴瘤的关联,并与假定相关性较低的弥漫性大 B 细胞淋巴瘤进行比较。
主成分分析表明,纵隔灰色区淋巴瘤具有独特的表观遗传特征,位于经典霍奇金淋巴瘤和原发性纵隔大 B 细胞淋巴瘤之间,但与弥漫性大 B 细胞淋巴瘤显著不同。对纵隔灰色区淋巴瘤、经典霍奇金淋巴瘤、原发性纵隔大 B 细胞淋巴瘤和弥漫性大 B 细胞淋巴瘤中常见的低甲基化和高甲基化 CpG 靶点进行了分析,并通过主成分分析证实了这一发现。基于表观遗传谱,我们能够利用 HOXA5、MMP9、EPHA7 和 DAPK1 等基因建立分类预测模型,这些模型可以区分纵隔灰色区淋巴瘤、经典霍奇金淋巴瘤和原发性纵隔大 B 细胞淋巴瘤,最终综合预测准确率为 100%。
我们的数据证实了纵隔灰色区淋巴瘤与经典霍奇金淋巴瘤和原发性纵隔大 B 细胞淋巴瘤之间存在密切关系。然而,也观察到了重要的差异,从而可以清楚地区分与这两个亲本实体。因此,纵隔灰色区淋巴瘤不能归为经典霍奇金淋巴瘤或原发性纵隔大 B 细胞淋巴瘤,这验证了在世界卫生组织分类中创建中间类别这一决定的合理性。